Hisham Keblawi, MD
Obstetrics & Gynecology · Huntington, WVNPI 1922144120
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 68 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Novo Nordisk at 43.0% of the total. Reporting peaked in 2024 at $482 and has fallen 70.7% since, to $141 in 2025.
Across 68 payments — averaging $16.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$494
- AstraZeneca$257
- Paratek Pharmaceuticals, Inc.$110
- Lilly USA, LLC$73
- Shield Therapeutics Inc$62
- Teva Pharmaceuticals USA, Inc.$37
- plus $117 from 6 others
Across 51 payments — averaging $3300.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$168K
What the payments were for
- Food & beverage$1,150100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 33 | $494 |
| AstraZeneca(2 entities) | 15 | $257 |
| Paratek Pharmaceuticals, Inc. | 6 | $110 |
| Lilly USA, LLC | 3 | $73 |
| Shield Therapeutics Inc | 3 | $62 |
| Teva Pharmaceuticals USA, Inc. | 2 | $37 |
| Applied Medical Resources Corporation | 1 | $33 |
| Meditrina | 1 | $27 |
| Insulet Corporation | 1 | $21 |
| Shire North American Group Inc | 1 | $14 |
| Sunovion Pharmaceuticals Inc. | 1 | $14 |
| Organon | 1 | $8 |
How this compares
$1,150 in reported general payments places this provider in the 60th percentile of 172 obstetrics & gynecology providers in West Virginia.
See all obstetrics & gynecology providers in West Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DottiEstradiol | 13 | $815 |
| Estradiol | 14 | $429 |
| Terconazole | 15 | $409 |
| Clobetasol Propionate | 16 | $228 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Huntington
- Amanda PauleyHuntington$26K
- Amber KuhlHuntington$7K
- Sukhmit KaurHuntington$3K
- Jared BrownfieldHuntington$2K
- David JudeHuntington$2K
- Joseph AssaleyHuntington$1K
- Jessica HottMartinsburg$194K
- Lori TuckerPrinceton$46K
- Stephen BushCharleston$33K
- Sarah DotsonMorgantown$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.